HI
CRL icon

Humankind Investments’s Charles River Laboratories CRL Stock Holding History

Humankind Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,305
Closed -$204K – 58
2025
Q3 		$204K Sell
1,305
-82
-6% -$13K 0.05% 144
2025
Q2 		$210K Buy
+1,387
New +$185K 0.05% 137
2023
Q1 		– Sell
-976
Closed -$213K – 121
2022
Q4 		$213K Sell
976
-105
-10% -$22.9K 0.09% 112
2022
Q3 		$213K Buy
+1,081
New +$233K 0.1% 102

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Humankind Investments's CRL Position: Q4 2025 in Review

Humankind Investments sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 1,305 shares — an estimated $204K sold.

Humankind Investments first reported a position in CRL in Q3 2022 and held it in 4 quarters. The position peaked at $213K in Q3 2022. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Humankind Investments reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 1,305 Charles River Laboratories shares in Q4 2025, an estimated $204K.
  • Humankind Investments first reported a position in Charles River Laboratories in Q3 2022 and held it in 4 quarters.
  • Humankind Investments's Charles River Laboratories position peaked at $213K in Q3 2022.
  • 580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.